Somavert : EPAR - Procedural steps taken before authorisation
Submitted by Anonymous (not verified) on 27 November 2023 - 1:00
Somavert : EPAR - Procedural steps taken before authorisation
Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous human corneal epithelial cells containing stem cells, Stem Cell Transplantation;Corneal Diseases, Date of authorisation: 17/02/2015, Revision: 10, Status: Aut
Submitted by Anonymous (not verified) on 24 November 2023 - 19:38
Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous human corneal epithelial cells containing stem cells, Stem Cell Transplantation;Corneal Diseases, Date of authorisation: 17/02/2015, Revision: 10, Status: Authorised
EVVet3 EVWeb Production – Release notes
Submitted by Anonymous (not verified) on 24 November 2023 - 16:48
EVVet3 EVWeb Production – Release notes
EVVET - EVWEB user manual
Submitted by Anonymous (not verified) on 24 November 2023 - 16:46
EVVET - EVWEB user manual
Human medicines European public assessment report (EPAR): Betaferon, interferon beta-1b, Multiple Sclerosis, Date of authorisation: 30/11/1995, Revision: 36, Status: Authorised
Submitted by Anonymous (not verified) on 24 November 2023 - 16:16
Human medicines European public assessment report (EPAR): Betaferon, interferon beta-1b, Multiple Sclerosis, Date of authorisation: 30/11/1995, Revision: 36, Status: Authorised
EFIM General Assembly 2024 - 6 March, Istanbul
Submitted by Aneta on 24 November 2023 - 16:11
We are pleased to announce that the following EFIM General Assembly will take place on Wednesday, 6 March 2024 at the Istanbul Congress Center in Turkey.
The meeting will take place prior to the 22nd European Congress of Internal Medicine, ECIM, 2024
To be able to register to the General Assembly, please follow the registration link:
https://efim.org/efim-general-assembly-2024-6-march-istanbul
Sixth Industry Standing Group (ISG) meeting, from 21/09/2023 to 21/09/2023
Submitted by Anonymous (not verified) on 24 November 2023 - 16:00
Sixth Industry Standing Group (ISG) meeting, from 21/09/2023 to 21/09/2023
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 09/11/2016, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 24 November 2023 - 15:57
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 09/11/2016, Revision: 8, Status: Authorised
Enpr-EMA newsletter 2022
Submitted by Anonymous (not verified) on 24 November 2023 - 15:24
Enpr-EMA newsletter 2022
Valproate: Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) - EMEA/H/N/PSR/J/0036
Submitted by Anonymous (not verified) on 24 November 2023 - 15:09
Valproate: Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) - EMEA/H/N/PSR/J/0036